Evidence map›Paper›PMID 31189528›Full record

ArticleBlood advances2019

B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency.

Benjamin Oshrine, Nanette Grana, Colin Moore, Johnny Nguyen, Melissa Crenshaw, Melissa Edwards, Sumedha Sudhaman, Victoria J Forster, Uri Tabori

Open access · goldAbstract readCase Reports
In one paragraph

Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Benjamin OshrineJohns Hopkins All Children's Hospital, St. Petersburg, FL; and.
Nanette GranaJohns Hopkins All Children's Hospital, St. Petersburg, FL; and.
Colin MooreJohns Hopkins All Children's Hospital, St. Petersburg, FL; and.
Johnny NguyenJohns Hopkins All Children's Hospital, St. Petersburg, FL; and.
Melissa CrenshawJohns Hopkins All Children's Hospital, St. Petersburg, FL; and.
Melissa EdwardsThe Hospital for Sick Children, Toronto, ON, Canada.
Sumedha SudhamanThe Hospital for Sick Children, Toronto, ON, Canada.
Victoria J ForsterThe Hospital for Sick Children, Toronto, ON, Canada.
Uri TaboriThe Hospital for Sick Children, Toronto, ON, Canada.
Hospital for Sick Children · CAJohns Hopkins All Children's Hospital · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, BispecificAntineoplastic Agents, ImmunologicalBone MarrowBrain NeoplasmsChildColorectal NeoplasmsFatal OutcomeHumansInotuzumab OzogamicinMaleMutationNeoplastic Syndromes, HereditaryPrecursor Cell Lymphoblastic Leukemia-LymphomaAntibodies, BispecificAntineoplastic Agents, ImmunologicalblinatumomabInotuzumab Ozogamicin

Identifiers

PMID31189528
PMCPMC6595266
OpenAlexW2949446975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.